Alteration of gene expression in normal-appearing colon mucosa of APC min mice and human cancer patients

Cancer Research

Volumn 64, Issue 10, 2004, Pages 3694-3700

  Chen, Ling Chun ^a   Hao, Chun Yi ^a   Chiu, Yanek S Y ^a   Wong, Patrick ^a   Melnick, Jane S ^a   Brotman, Martin ^a   Moretto, John ^a   Mendes, Fredrick ^a   Smith, Andrew P ^a   Bennington, James L ^a   Moore, Dan ^a   Lee, Nancy M ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER PATIENT; CANCER RISK; CANCER SURGERY; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; COLON RESECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MOUSE STRAIN; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADENOMATOUS POLYPOSIS COLI; AGED; ANIMALS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; INTESTINAL MUCOSA; ISOENZYMES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 2442649255     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3264     Document Type: Article

References (31)

1. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001;61:3124-30.
2. Giordano TJ, Shedden KA, Schwartz DR, et al. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol 2001;159:1231-8.
3. Kitahara O, Furukawa Y, Tanaka T, et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res 2001;61:3544-9.
4. Tureci O, Ding J, Hillon H, et al. Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles. FASEB J 2003;17:376-85.
5. Muro S, Takemasa I, Oba S, et al. Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data. Genome Biol 2003;4:R21.
6. Guda K, Cui H, Garg S, et al. Multistage gene expression profiling in a differentially susceptible mouse colon cancer model. Cancer Lett 2003;191:17-25.
7. Lin YM, Ono K, Satoh S, et al. Identification of AFI7 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis. Cancer Res 2001;61:6345-9.
8. Williams NS, Gaynor RB, Scoggin S, et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 2003;9:931-46.
9. Buckhaults P, Rago C, St. Croix B, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001;61:6996-7001.
10. Hegde P, Qi R, Gaspard R, et al. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res 2001;61:7792-7.
11. Ieda S, Watatani M, Yoshida T, Kuroda K, Inui H, Yasutomi M. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas. Surg Today 1996;26:230-5.
12. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science (Wash DC) 1998;281:1509-12.
13. Koh TJ, Bulitta CJ, Fleming JV, Dockray GJ, Varro A, Wang TC. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J Clin Investig 2000;106:533-9.
14. Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000;60: 3689-95.
15. Bianchi E, Cohen RL, Thor AT, et al. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 1994;54:861-6.
16. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8.
17. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res 2001;7: 3298-304.
18. Smith RA, Eschenbach AC, Wender R. American Cancer Society guidelines on screen and surveillance for the early detection of adenomatous polyps and colorectal cancer. CA Cancer J Clin 2001;51:44-54.
19. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Investig 2001;107:1055-61.
20. Oshima M, Dinchuk JE, Kargman SL, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
21. Loukinova E, Dong G, Enamorado-Ayalya I, et al. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 2000;19:3477-86.
22. Siu IM, Robinson DR, Schwartz S, et al. The identification of monoclonality in human aberrant crypt foci. Cancer Res 1999;59:63-6.
23. Paulsen JE, Steffensen IL, Loberg EM, Husoy T, Namork E, Alexander J. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res 2001;61:5010-5.
24. Roy HK, Karolski WJ, Ratashak A. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone. Int J Cancer 2001;92:609-15.
25. Gupta RA, DuBois RN. Aspirin, NSAIDS, and colon cancer prevention: mechanisms? Gastroenterology 1998;114:1095-8.
26. Hull MA, Booth JK, Tisbury A, et al. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. Br J Cancer 1999;79:1399-405.
27. Bamba H, Ota S, Kato A, Adachi A, Iioyama S, Matsuzaki F. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer 1999;83: 470-5.
28. Inaba T, Sano H, Kawahito Y, et al. Induction of cyclooxygenase-2 in monocyte/ macrophage by mucins secreted from colon cancer cells. Proc Natl Acad Sci USA 2003;100:2736-41.
29. Muller-Decker K, Neufang G, Berger I, Neumann M, Marks F, Furstenberger G. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci USA 2002;99:12483-8.
30. Coussens LM, Werb Z. Inflammation and cancer. Nature (Lond) 2002;420:860-7.
31. Marnett LJ, DuBois RN. COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol 2002;42:55-80.